Fiduciary Alliance’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.96M Buy
366,282
+197,867
+117% +$5.27M 0.6% 44
2025
Q4
$4.19M Buy
168,415
+23,152
+16% +$584K 0.27% 86
2025
Q3
$3.7M Buy
145,263
+46,043
+46% +$1.14M 0.25% 94
2025
Q2
$2.41M Buy
99,220
+89,635
+935% +$2.09M 0.18% 125
2025
Q1
$243K Sell
9,585
-218
-2% -$5.7K 0.02% 346
2024
Q4
$260K Buy
9,803
+1,319
+16% +$35.8K 0.03% 308
2024
Q3
$246K Buy
8,484
+1,140
+16% +$33.3K 0.03% 223
2024
Q2
$204K Buy
+7,344
New +$202K 0.03% 202
2023
Q4
Sell
-6,261
Closed -$208K 190
2023
Q3
$208K Buy
6,261
+2,772
+79% +$98K 0.05% 155
2023
Q2
$128K Buy
+3,489
New +$136K 0.03% 185
2023
Q1
Sell
-2,034
Closed -$104K 644
2022
Q4
$104K Buy
+2,034
New +$97.5K 0.03% 160

Other funds holding PFE

Fiduciary Alliance's PFE Position: Q1 2026 in Review

Fiduciary Alliance increased its Pfizer (PFE) stake by 117% in Q1 2026, buying an estimated $5.27M and bringing the position to 366,282 shares worth $9.96M. The position accounts for 0.6% of the portfolio, ranked #44.

Fiduciary Alliance first reported a position in PFE in Q4 2022 and has held it in 11 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Fiduciary Alliance held 366,282 shares of Pfizer worth $9.96M as of Q1 2026.
  • Fiduciary Alliance bought 197,867 Pfizer shares in Q1 2026, an estimated $5.27M.
  • Pfizer made up 0.6% of Fiduciary Alliance's portfolio in Q1 2026, its #44 holding.
  • Fiduciary Alliance first reported a position in Pfizer in Q4 2022 and has held it in 11 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Fiduciary Alliance's 13F filing for Q1 2026, filed 20 Apr 2026.